We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+4.9%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$16.8B
AUM Growth
+$1.95B
(+13%)
Cap. Flow
+$1.49B
Cap. Flow
% of AUM
8.85%
Top 10 Holdings %
Top 10 Hldgs %
30.31%
Holding
2,964
New
179
Increased
2,266
Reduced
433
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$118M |
| 2 |
Apple
AAPL
|
+$96.6M |
| 3 |
NVIDIA
NVDA
|
+$91.2M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
Meta Platforms (Facebook)
META
|
+$38.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$92.7M |
| 2 |
Super Micro Computer
SMCI
|
+$18M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$14.4M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$14.1M |
| 5 |
Strategy Inc
MSTR
|
+$10.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.48% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.37% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Citi Trends
CTRN
$617M
| $44.1K | ﹤0.01% |
+2,076
| New | +$47.7K |
|
2777
Pyxis Oncology
PYXS
$201M
| $44.1K | ﹤0.01% |
+13,334
| New | +$56.1K |
|
2778
Redwire
RDW
$3.37B
| $44K | ﹤0.01% |
+6,137
| New | +$29.5K |
|
|
FREE
2779
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $43.1K | ﹤0.01% |
+8,875
| New | +$42.8K |
|
2780
Achieve Life Sciences
ACHV
$687M
| $42.6K | ﹤0.01% |
+9,054
| New | +$43.6K |
|
|
CALB
2781
DELISTED
California BanCorp Common Stock
CALB
| $42.5K | ﹤0.01% |
+1,979
| New | +$42.7K |
|
|
FSP
2782
Franklin Street Properties
FSP
$46.3M
| $42.5K | ﹤0.01% |
+27,800
| New | +$52.3K |
|
2783
BigBear.ai
BBAI
$1.56B
| $42K | ﹤0.01% |
+27,818
| New | +$43.5K |
|
2784
Clarivate
CLVT
$1.19B
| $41.6K | ﹤0.01% |
7,311
-1,710
| -19% | -$10.9K |
|
2785
Rigetti Computing
RGTI
$6.15B
| $41.5K | ﹤0.01% |
+38,793
| New | +$44.8K |
|
2786
Lucid Motors
LCID
$2.58B
| $41.5K | ﹤0.01% |
1,590
+137
| +9% | +$3.66K |
|
2787
Shattuck Labs
STTK
$752M
| $41.4K | ﹤0.01% |
+10,737
| New | +$87.3K |
|
2788
Heritage Insurance Holdings
HRTG
$980M
| $41.4K | ﹤0.01% |
+5,846
| New | +$51.7K |
|
|
PVBC
2789
DELISTED
Provident Bancorp
PVBC
| $40.9K | ﹤0.01% |
+4,011
| New | +$37K |
|
2790
Foghorn Therapeutics
FHTX
$394M
| $39.9K | ﹤0.01% |
+6,940
| New | +$41.3K |
|
|
PINC
2791
DELISTED
Premier
PINC
| $39.8K | ﹤0.01% |
2,132
-180
| -8% | -$3.57K |
|
2792
Atossa Therapeutics
ATOS
$23.5M
| $39.8K | ﹤0.01% |
+2,227
| New | +$49.3K |
|
2793
Ispire Technology
ISPR
$99.3M
| $39.6K | ﹤0.01% |
4,952
-5,531
| -53% | -$35.7K |
|
2794
Quest Resource Holding
QRHC
$30M
| $39.5K | ﹤0.01% |
+4,490
| New | +$41.4K |
|
2795
ADT
ADT
$5.34B
| $39.5K | ﹤0.01% |
5,196
+208
| +4% | +$1.44K |
|
2796
TripAdvisor
TRIP
$1.26B
| $39.1K | ﹤0.01% |
2,197
+101
| +5% | +$2.19K |
|
|
ELEV
2797
DELISTED
Elevation Oncology
ELEV
| $39.1K | ﹤0.01% |
+14,465
| New | +$54.5K |
|
2798
Arq
ARQ
$100M
| $39K | ﹤0.01% |
+6,433
| New | +$44.4K |
|
2799
Bel Fuse Inc Class A
BELFA
$3.43B
| $38.8K | ﹤0.01% |
+479
| New | +$36.1K |
|
2800
Cibus
CBUS
$144M
| $38.7K | ﹤0.01% |
+3,931
| New | +$59.4K |
|
Similar funds
SPIA
BG
PCM
CS
HHII
LF
EIM
MetLife Investment Management's Q2 2024 Portfolio in Review
As of Q2 2024, MetLife Investment Management held 2,964 positions worth $16.8B, up 13% from $14.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
MetLife Investment Management deployed $1.49B of net new capital in Q2 2024, opening 179 new positions and adding to 2,266 existing holdings. Its largest new stake was GE Vernova: 73,079 shares worth $12.5M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $92.7M trimmed.
- MetLife Investment Management's largest Q2 2024 buy was GE Vernova: 73,079 shares worth $12.5M.
- MetLife Investment Management added most to Microsoft in Q2 2024, an estimated $118M increase.
- MetLife Investment Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $92.7M.
- MetLife Investment Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $14.4M.
- MetLife Investment Management's ten largest holdings make up 30% of its $16.8B portfolio in Q2 2024.
- MetLife Investment Management opened 179 new positions and closed 84 in Q2 2024.
- MetLife Investment Management's portfolio value rose 13% quarter-over-quarter to $16.8B.
Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.